Hedge Fund - OrbiMed Advisors
Bristol Myers Squibb Co (BMY)
Holding History Records
| No. | Filing Period | Value | % of Portfolio | Number of Shares | Avg. Quarterly Share Price |
|---|---|---|---|---|---|
| 1 | 2023 - Q3 (2023-09-30) | $0 | 0% | 0 | $61.27 |
| 2 | 2023 - Q2 (2023-06-30) | $95,157,600 | 1.72% | 1,488,000 | $67.06 |
| 3 | 2023 - Q1 (2023-03-31) | $162,185,400 | 3.18% | 2,340,000 | $70.53 |
| 4 | 2022 - Q4 (2022-12-31) | $185,983,555 | 3.55% | 2,584,900 | $75.40 |
| 5 | 2022 - Q3 (2022-09-30) | $183,761,000 | 3.41% | 2,584,900 | $72.54 |
| 6 | 2022 - Q2 (2022-06-30) | $193,940,000 | 3.51% | 2,518,700 | $76.16 |
| 7 | 2022 - Q1 (2022-03-31) | $190,440,000 | 3.08% | 2,607,700 | $67.14 |
| 8 | 2021 - Q4 (2021-12-31) | $270,587,000 | 3.47% | 4,339,800 | $58.66 |
| 9 | 2021 - Q3 (2021-09-30) | $267,176,000 | 2.93% | 4,515,400 | $65.86 |
| 10 | 2021 - Q2 (2021-06-30) | $301,719,000 | 3.05% | 4,515,400 | $65.21 |
| 11 | 2021 - Q1 (2021-03-31) | $285,057,000 | 2.66% | 4,515,400 | $62.22 |
| 12 | 2020 - Q4 (2020-12-31) | $220,151,000 | 1.92% | 3,549,100 | $61.49 |
| 13 | 2020 - Q3 (2020-09-30) | $213,975,000 | 2.68% | 3,549,100 | $60.19 |
| 14 | 2020 - Q2 (2020-06-30) | $169,473,000 | 2.38% | 2,882,200 | $59.81 |
| 15 | 2020 - Q1 (2020-03-31) | $137,945,000 | 2.31% | 2,474,800 | $61.12 |
| 16 | 2019 - Q4 (2019-12-31) | $109,123,000 | 1.55% | 1,700,000 | $57.27 |
| 17 | 2019 - Q3 (2019-09-30) | $0 | 0% | 0 | $47.00 |
| 18 | 2019 - Q2 (2019-06-30) | $61,005,000 | 0.94% | 1,345,200 | $46.58 |
| 19 | 2019 - Q1 (2019-03-31) | $57,013,000 | 0.88% | 1,195,000 | $49.81 |
| 20 | 2018 - Q4 (2018-12-31) | $26,297,000 | 0.48% | 505,900 | $53.73 |
| 21 | 2018 - Q3 (2018-09-30) | $125,762,000 | 1.51% | 2,025,800 | $59.34 |
| 22 | 2018 - Q2 (2018-06-30) | $131,726,000 | 1.57% | 2,380,300 | $54.01 |
| 23 | 2018 - Q1 (2018-03-31) | $232,463,000 | 2.88% | 3,675,300 | $64.33 |
| 24 | 2017 - Q4 (2017-12-31) | $42,161,000 | 0.53% | 688,000 | $62.55 |
| 25 | 2017 - Q3 (2017-09-30) | $55,753,000 | 0.53% | 874,700 | $58.39 |
| 26 | 2017 - Q2 (2017-06-30) | $48,738,000 | 0.51% | 874,700 | $54.42 |
| 27 | 2017 - Q1 (2017-03-31) | $103,920,000 | 1.17% | 1,911,000 | $54.85 |
| 28 | 2016 - Q4 (2016-12-31) | $87,280,000 | 1.11% | 1,493,500 | $54.67 |
| 29 | 2016 - Q3 (2016-09-30) | $117,945,000 | 1.34% | 2,187,400 | $64.24 |
| 30 | 2016 - Q2 (2016-06-30) | $371,839,000 | 3.88% | 5,055,600 | $70.66 |
| 31 | 2016 - Q1 (2016-03-31) | $487,079,000 | 5.12% | 7,624,900 | $63.06 |
| 32 | 2015 - Q4 (2015-12-31) | $577,492,000 | 5.22% | 8,395,000 | $66.08 |
| 33 | 2015 - Q3 (2015-09-30) | $513,152,000 | 5.18% | 8,668,100 | $63.44 |
| 34 | 2015 - Q2 (2015-06-30) | $515,758,000 | 4.31% | 7,751,100 | $65.90 |
| 35 | 2015 - Q1 (2015-03-31) | $572,941,000 | 4.89% | 8,882,800 | $62.60 |
| 36 | 2014 - Q4 (2014-12-31) | $453,864,000 | 4.33% | 7,688,700 | $56.40 |
| 37 | 2014 - Q3 (2014-09-30) | $373,205,000 | 3.89% | 7,292,000 | $49.95 |
| 38 | 2014 - Q2 (2014-06-30) | $348,738,000 | 4.09% | 7,189,000 | $49.28 |
| 39 | 2014 - Q1 (2014-03-31) | $309,954,000 | 3.81% | 5,966,400 | $53.21 |
| 40 | 2013 - Q4 (2013-12-31) | $290,465,000 | 4.26% | 5,465,000 | $50.94 |
| 41 | 2013 - Q3 (2013-09-30) | $240,841,000 | 4.29% | 5,204,000 | $43.90 |
| 42 | 2013 - Q2 (2013-06-30) | $148,460,000 | 3.14% | 3,322,000 | $43.41 |
| 43 | 2013 - Q1 (2013-03-31) | $169,332,000 | 3.93% | 4,111,000 | $36.69 |
| 44 | 2012 - Q4 (2012-12-31) | $55,729,000 | 1.71% | 1,710,000 | $32.90 |
| 45 | 2012 - Q3 (2012-09-30) | $90,858,000 | 2.6% | 2,692,100 | $33.67 |
| 46 | 2012 - Q1 (2012-03-31) | $148,676,000 | 4.41% | 4,405,200 | $32.92 |
| 47 | 2011 - Q4 (2011-12-31) | $136,745,000 | 4.48% | 3,880,400 | $32.57 |
| 48 | 2011 - Q3 (2011-09-30) | $105,587,000 | 3.91% | 3,364,800 | $29.13 |
| 49 | 2011 - Q2 (2011-06-30) | $142,391,000 | 2.64% | 4,916,800 | $28.08 |
| 50 | 2011 - Q1 (2011-03-31) | $136,067,000 | 4.58% | 5,148,200 | $25.90 |
| 51 | 2010 - Q4 (2010-12-31) | $104,755,000 | 3.77% | 3,956,000 | $26.51 |
The displayed share prices are average quarterly stock market prices.